The union for managers and professionals in public service
Home  >  News and media  >  Press releases  >  Scottish Government doesn’t truly value the work of FDA members
Wednesday 12 December 2018

Scottish Government doesn’t truly value the work of FDA members

Responding to the announcement of the Scottish Government’s public sector pay policy, FDA National Officer Allan Sampson said:

“Whilst we support increasing the pay of the lowest paid workers, it’s important to remember that FDA members have also suffered from nearly a decade of pay restraint.

“The split nature of this pay policy sends a message that the Scottish Government doesn’t truly value the vital work carried out by our members in Scotland.

“It is our members in the senior and professionals ranks who lag furthest behind their private sector counterparts - this policy risks creating barriers to effective pay settlements, limiting the Scottish Government’s ability to recruit and retain the talented staff it needs.”
Notes for editors
1. The FDA is the union for senior managers and professionals in public service, representing more than 18,000 members at grades HEO and above. Membership includes senior civil servants, government policy advisors, prosecutors, diplomats, tax professionals, economists, solicitors and other professionals working across the Government and the NHS. 
2. The FDA (formerly the First Division Association) should be referred to simply as "The FDA" and can be described as "the senior public servants' union". 
3. The FDA can be found on Twitter @FDA_union and at www.fda.org.uk. General Secretary Dave Penman tweets as @FDAGenSec. 
4. For more information contact: 
FDA Communications Officer Tommy Newell on 020 7401 5588 or 07738 729 145 or email on tommy@fda.org.uk
FDA Communications Officer Laura Gilbert on 020 7401 5589 or email on laura.gilbert@fda.org.uk 
5. The Scottish Government's public sector pay policy can be viewed here.
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA